Skip to content

Clinical trials

Phase 2 Liver Cirrhosis, Biliary trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis, Biliary Phase: Phase 2 Country / region: United States Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20072
20081
20101
20112
20132
20142
20153
20162
20176
20192
20212
20223
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated7
Withdrawn2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Intercept Pharmaceuticals4
Gilead Sciences3
Mirum Pharmaceuticals, Inc.3
Mayo Clinic2
NGM Biopharmaceuticals, Inc2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
Arena Pharmaceuticals1
Calliditas Therapeutics AB1
Calliditas Therapeutics Suisse SA1
Cara Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis, Biliary33
Pruritus6
Cholestasis3
Cholangitis2
Cholangitis, Sclerosing2
Fibrosis2
Biliary Tract Diseases1
Digestive System Diseases1
Fatigue1
Hepatitis C1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.